Ibrutinib for treatment of autoimmune cytopenia after hematopoietic stem cell transplantation: report of 2 cases and literature review
Objective To explore the curative effect of ibrutinib in treatment of autoimmune cytopenia (AIC) after hematopoietic stem cell transplantation (HSCT). Methods Two leukemia patients receiving HSCT at our hospital in 2016 and 2018 respectively were enrolled in this study, who were subsequently diagno...
Guardado en:
Autores principales: | WEI Ruowen, CHEN Wenlan, XIE Rong, XIA Linghui, YOU Yong |
---|---|
Formato: | article |
Lenguaje: | ZH |
Publicado: |
Editorial Office of Journal of Third Military Medical University
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f3a8d1dd777d44119a782ffca3a57081 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Successful rituximab therapy in refractory autoimmune hepatitis and Evans syndrome
por: Carey,Elizabeth J, et al.
Publicado: (2011) -
A New Murine Model of Primary Autoimmune Hemolytic Anemia (AIHA)
por: Flavia Dei Zotti, et al.
Publicado: (2021) -
Anemia hemolítica autoinmune en Chile: un análisis retrospectivo de 43 pacientes
por: López-Vidal,Hernán, et al.
Publicado: (2019) -
Tratamiento de anemia aplásica severa adquirida en pacientes pediátricos con inmunosupresión y trasplante alogénico de precursores hematopoiéticos
por: Barriga C,Francisco, et al.
Publicado: (2007) -
Aplasia medular adquirida, experiencia en un hospital público de referencia
por: León,Pilar, et al.
Publicado: (2018)